Multiple primary malignant neoplasms of the mouth and oropharynx

Cover Page

Cite item

Full Text

Abstract

Introduction. Probability of development of multiple primary tumors in patients who received treatment due to head and neck cancers varies between 5.6 and 35.9 % per different sources. moreover, treatment capabilities are severely limited by postoperative anatomical changes and previous radiation therapy, and the second tumor frequently causes death in these patients.

The study objective is to identify the epidemiological features of the development of synchronous and metachronous primary multiple tumors in the head and neck.

Materials and methods. The article analyzes data on 103 patients with multiple primary tumors who received treatment due to tumors of the head and neck between 1991 and 2020 at the N.N. Blokhin National medical Research Center of Oncology and A.S. Loginov Moscow Clinical Scientific Center.

Results. During the study, typical locations of metachronous tumors in patients who received treatment due to primary malignant tumors of the head and neck were determined, duration of development of multiple primary tumors, treatment methods and survival rates were analyzed.

Conclusion. Due to high risk of multiple primary tumors in patients who received treatment due to malignant tumors of the head and neck in the next 5 plus years, it is expedient to observe these patients during their whole lifetime. Considering typical locations of metachronous tumors, examination during dynamic observation should include instrumental methods such as panendoscopy. Surgical treatment should involve the whole spectrum of minimally invasive interventions including CO2 laser surgery and transoral robot-assisted interventions.

About the authors

M. A. Kropotov

N.N. Blokhin National Medical Research Center of Oncology, Ministry of Health of Russia

Author for correspondence.
Email: drkropotov@mail.ru
ORCID iD: 0000-0002-9132-3416

Mikhail A. Kropotov.

23 Kashirskoe Shosse, Moscow 115478.

Russian Federation

L. P. Yakovleva

A.S. Loginov Moscow Clinical Scientific Center of the Moscow Healthcare Department

Email: fake@neicon.ru
ORCID iD: 0000-0002-7356-8321

86 Shosse Entuziastov, Moscow 111123.

Russian Federation

L. G. Zhukova

A.S. Loginov Moscow Clinical Scientific Center of the Moscow Healthcare Department

Email: fake@neicon.ru

86 Shosse Entuziastov, Moscow 111123.

Russian Federation

G. O. Agabekyan

N.N. Burdenko National Medical Research Center of Neurosurgery, Ministry of Health of Russia

Email: fake@neicon.ru

16 4th Tverskaya-Yamskaya St., Moscow 125047.

Russian Federation

A. V. Khodos

A.S. Loginov Moscow Clinical Scientific Center of the Moscow Healthcare Department

Email: fake@neicon.ru
ORCID iD: 0000-0001-5706-912X

86 Shosse Entuziastov, Moscow 111123.

Russian Federation

D. A. Safarov

N.N. Blokhin National Medical Research Center of Oncology, Ministry of Health of Russia

Email: fake@neicon.ru
ORCID iD: 0000-0003-2793-5597

23 Kashirskoe Shosse, Moscow 115478.

Russian Federation

P. A. Gavrishchuk

A.S. Loginov Moscow Clinical Scientific Center of the Moscow Healthcare Department

Email: fake@neicon.ru

86 Shosse Entuziastov, Moscow 111123.

Russian Federation

M. S. Tigrov

A.S. Loginov Moscow Clinical Scientific Center of the Moscow Healthcare Department

Email: fake@neicon.ru

86 Shosse Entuziastov, Moscow 111123.

Russian Federation

A. S. Vyalov

A.S. Loginov Moscow Clinical Scientific Center of the Moscow Healthcare Department

Email: fake@neicon.ru

86 Shosse Entuziastov, Moscow 111123.

Russian Federation

References

  1. Gonzalez-Garda R., Naval-G^as L., Roman-Romero L. et al. Local recurrences and second primary tumors from squamous cell carcinoma of the oral cavity: a retrospective analytic study of 500 patients. Head Neck 2009;31(9):1168-80. doi: 10.1002/hed.21088.
  2. Yamashita T., Araki K., Tomifuji M. et al. Clinical features and treatment outcomes of Japanese head and neck cancer patients with a second primary cancer. Asia Pac J Clin Oncol 2017;13(3):172-8. doi: 10.1111/ajco.12599.
  3. Boakye E.A., Buchanan P., Hinyard L. et al. Incidence and risk of second primary malignant neoplasm after a first head and neck squamous cell carcinoma. JAMA Otolaryngol Head Neck Surg 2018;144(8):727-37. doi: 10.1001/jamaoto.2018.0993.
  4. Warren S., Gates O. Multiple primary malignant tumors: a survey of the literature and a statistical study. Am J Cancer 1932;16:1358-414.
  5. Boakye E.A., Buchanan P., Hinyard L. et al. Trends in the risk and burden of second primary malignancy among-survivors of smoking-related cancers in the United States. Int J Cancer 2019;145(1): 143-53. doi: 10.1002/ijc.32101.
  6. Jones A.S., Morar P., Phillips D.E. Second primary tumors in patients with head and neck squamous cell carcinoma. Cancer 1995;75(6):1343-53. doi: 10.1002/1097-0142(19950315)75:6<1343::aid-cncr2820750617>3.0.co;2-t.
  7. Adeel M., Siddiqi M.I. Metachronous second primary malignancy in head and neck cancer patients: is five years of follow-up sufficient. J Korean Assoc Oral Maxillofac Surg 2018;44(5):220-4. doi: 10.5125/jkaoms.2018.44.5.220.
  8. Frolov I.M., Kudinova E.A., Rozhkova N.I. Clinical and molecular genetic features of primary multiple cancer. Vestnik Rossijskogo Nauchnogo Centra Rentgenoradiologii Minzdrava Rossii = Bulletin of the Russian Scientific Center of Radiology of the Ministry of Health of Russia 2012;1(12):28-31. (In Russ.).
  9. Bunbanjerdsuk S., Vorasan N., Saethang T. et al. Oncoproteomic and gene expression analyses identify prognostic biomarkers for second primary malignancy in patients with head and neck squamous cell carcinoma. Mod Pathol 2019;32(7):943-56. doi: 10.1038/s41379-019-0211-2.

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c)



СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № ФС 77 - 36990 от  21.07.2009.